F-18-Fluorodeoxyglucose PET Imaging Alters Clinical Decision Making in Patients With Impaired Ventricular Function

The effect of F-18-fluorodeoxyglucose positron emission tomography imaging on decision making in the selection of patients with impaired ventricular function for revascularization was determined in 87 patients. In 57% of patients, positron emission tomography data influenced management decisions, in...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 1997-04, Vol.79 (8), p.1092-1095
Main Authors: Beanlands, Rob S.B., deKemp, Robert A., Smith, Stuart, Johansen, Helen, Ruddy, Terence D., Aung, May, Aubrey, Barbara
Format: Article
Language:English
Subjects:
Aged
Cardiovascular disease
Coronary Disease - complications
Coronary Disease - diagnostic imaging
Coronary Disease - metabolism
Coronary Disease - surgery
Decision Making
Deoxyglucose - analogs & derivatives
Female
Fluorine Radioisotopes
Fluorodeoxyglucose F18
Humans
Male
Medical imaging
Middle Aged
Myocardial Revascularization
Myocardium - metabolism
Patients
Prospective Studies
Tomography, Emission-Computed - methods
Ventricular Dysfunction, Left - diagnostic imaging
Ventricular Dysfunction, Left - etiology
Ventricular Dysfunction, Left - metabolism
Ventricular Dysfunction, Left - surgery
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The effect of F-18-fluorodeoxyglucose positron emission tomography imaging on decision making in the selection of patients with impaired ventricular function for revascularization was determined in 87 patients. In 57% of patients, positron emission tomography data influenced management decisions, indicating an important effect of myocardial viability determination on difficult therapy decisions in these patients.
ISSN:0002-9149
1879-1913
DOI:10.1016/S0002-9149(97)00054-4